Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodixanol vs Iopamidol in Peripheral Arteriography
NCT01475097Phase 4Completed
- Sponsor
- GE HealthCare
- Start
- Oct 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iodixanol in Peripheral Arterial Disease (PAD), sponsored by GE HealthCare. Started Oct 2011; status: completed.
02
Drugs
iodixanol
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT01475097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475097.